Autoimmune Disease Diagnostics Market Size, Share, Growth, Trends and Industry Analysis Reportby Susan Hill Business Consultant
The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.
Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.
Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.
Further key findings from the study suggest:
autoimmune disease diagnostics was the largest segment in 2015 owing to
high usage for type 1 diabetes and idiopathic thrombocytopenic purpura
- Type 1 diabetes
is estimated to grow at a significant growth rate of over 4.0% in
localized disease type segment
disease diagnostics is anticipated to witness lucrative CAGR of around
5.0% over the forecast period due to increasing R&D for the
development of novel diagnostic biomarkers for the treatment of rheumatoid
arthritis and systemic lupus erythematosus
arthritis is one of the most recurring autoimmune disorders further
demanding high amount of rapid diagnostics for exploring better
- North America
was the largest regional market in 2015. High market penetration rate of
technologically advanced products and increased lab automation rate are
some of the factors contributing to its large share
- Asia Pacific
region is anticipated to grow at the fastest CAGR of above 4.0% over the
forecast period owing to increasing focus on type 1 diabetes diagnosis
- Some of the key players of this market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU. Diagnostics; Inova Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.
Access full research report on global autoimmune disease diagnostics market:
Created on Jan 2nd 2020 06:08. Viewed 297 times.